CHA Biotech is deeply committed to ESG principles as the foundation of its business practices.
The company respects the human rights of all stakeholders—employees, customers, shareholders, and business partners—and works tirelessly to promote and protect those rights.
By proactively identifying and mitigating potential human rights risks, CHA Biotech aims to prevent violations before they occur. In the event of an issue, the company responds swiftly to resolve the problem and prevent future occurrences.
CHA Biotech pledges to uphold international human rights standards, labor regulations, and both global and local laws, integrating them into all aspects of its business.
Sang Hoon Oh, CEO, CHA Biotech Co., Ltd.